MedTrace Logo

Korean Hereditary Breast Cancer Study

NCT00595348 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2250

Last updated 2011-05-11

No results posted yet for this study

Summary

1. To evaluate the prevalence of BRCA1/2 mutation of breast cancer patients with family history of breast/ovarian cancer.
2. To evaluate the prevalence of BRCA1/2 mutation of breast cancer patients without family history, but high risk of hereditary cancer.
3. To evaluate the prevalence of BRCA1/2 mutation of family member of BRCA1/2 mutation.
4. To evaluate the prevalence of ovarian cancer of population of above 3 groups.

Conditions

Sponsors & Collaborators

  • Korean Breast Cancer Study Group

    lead OTHER

Principal Investigators

  • Sung-Won Kim, M.D, Ph.D. · Department of Surgery, Breast & Endocrine Service, Seoul National University Bundang Hospital

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-11-30
Primary Completion
2012-05-31
Completion
2017-05-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00595348 on ClinicalTrials.gov